TY - JOUR
T1 - Ethical Implementation of Organ Donation Following Medical Assistance in Dying
T2 - Recommendations of the Ethics Committee of the Transplantation Society
AU - Van Assche, Kristof
AU - Mulder, Johannes
AU - Ahn, Curie
AU - Allen, Richard D.M.
AU - Bollen, Jan
AU - Bramstedt, Katrina A.
AU - Burra, Patrizia
AU - Cras, Patrick
AU - Dhital, Kumud
AU - Dittmer, Ian
AU - Domínguez-Gil, Beatriz
AU - Downar, James
AU - Fadhil, Riadh A.S.
AU - Ferdinande, Patrick
AU - Forsythe, John L.R.
AU - Fortin, Marie Chantal
AU - Freeman, Michael A.
AU - Gerritsen, Rik T.
AU - Grayson, Kim E.
AU - Healey, Andrew
AU - Kazemi, Alex
AU - Kute, Vivek B.
AU - Martin, Dominique E.
AU - Monbaliu, Diethard
AU - Muller, Elmi
AU - Nino-Murcia, Alejandro
AU - Olthuis, Gert
AU - Opdam, Helen I.
AU - Parent, Brendan
AU - Pérez Blanco, Alicia
AU - Shemie, Sam D.
AU - Siebelink, Marion
AU - Silva, Amina
AU - Silva e Silva, Vanessa
AU - Sonneveld, Hans P.
AU - Stock, Peter G.
AU - ten Hoopen, Rankie
AU - Thiessen, Carrie
AU - van Mook, Walther
AU - Van Raemdonck, Dirk
AU - Wall, Anji E.
AU - Weiss, Matthew J.
AU - Woodyatt, Larna
AU - Ysebaert, Dirk
AU - Thomson, David
N1 - Publisher Copyright:
Copyright © 2026 The Author(s). Published by Wolters Kluwer Health, LLC.
PY - 2026/9/1
Y1 - 2026/9/1
N2 - Background. – Medical assistance in dying (MAiD) is legally permitted in a growing number of jurisdictions, and in 6, it can currently be followed by organ donation. Organ donation following MAiD offers patients an opportunity to address transplant needs as a final act of altruism, but it also raises complex ethical questions that require strong safeguards to protect patients, professionals, and public trust. Methods. – We identified key ethical issues and safeguards by analyzing guidelines and protocols from the 6 countries where organ donation following MAiD is performed: Australia, Belgium, Canada, the Netherlands, New Zealand, and Spain. This article was developed under the auspices of the Ethics Committee of The Transplantation Society with medical, ethical, and legal experts from these countries. Results. – Three domains of ethical concern emerged: (1) safeguarding the integrity of patients’ decision-making (voluntariness, informed consent, and how and when information is presented); (2) ethical governance of donation following MAiD (adherence to the Dead Donor Rule, death determination, and consent for premortem interventions); and (3) implications for care relationships and professional practice (end-of-life impacts, recipient information and donor anonymity, and professional support, including conscientious objection). Key recommendations include clear and consistent policies; a patient-centered, nondirective approach; rigorous eligibility and voluntariness assessments; and strict separation between MAiD and donation/transplantation teams. Conclusions. – These recommendations provide practical guidance for implementing organ donation following MAiD in jurisdictions where it is practiced or being considered. They support patients’ end-of-life wishes while safeguarding ethical and legal standards and maintaining trust in both MAiD and organ transplantation.
AB - Background. – Medical assistance in dying (MAiD) is legally permitted in a growing number of jurisdictions, and in 6, it can currently be followed by organ donation. Organ donation following MAiD offers patients an opportunity to address transplant needs as a final act of altruism, but it also raises complex ethical questions that require strong safeguards to protect patients, professionals, and public trust. Methods. – We identified key ethical issues and safeguards by analyzing guidelines and protocols from the 6 countries where organ donation following MAiD is performed: Australia, Belgium, Canada, the Netherlands, New Zealand, and Spain. This article was developed under the auspices of the Ethics Committee of The Transplantation Society with medical, ethical, and legal experts from these countries. Results. – Three domains of ethical concern emerged: (1) safeguarding the integrity of patients’ decision-making (voluntariness, informed consent, and how and when information is presented); (2) ethical governance of donation following MAiD (adherence to the Dead Donor Rule, death determination, and consent for premortem interventions); and (3) implications for care relationships and professional practice (end-of-life impacts, recipient information and donor anonymity, and professional support, including conscientious objection). Key recommendations include clear and consistent policies; a patient-centered, nondirective approach; rigorous eligibility and voluntariness assessments; and strict separation between MAiD and donation/transplantation teams. Conclusions. – These recommendations provide practical guidance for implementing organ donation following MAiD in jurisdictions where it is practiced or being considered. They support patients’ end-of-life wishes while safeguarding ethical and legal standards and maintaining trust in both MAiD and organ transplantation.
U2 - 10.1097/TP.0000000000005812
DO - 10.1097/TP.0000000000005812
M3 - Article
SN - 0041-1337
VL - 110
SP - e1840-e1851
JO - Transplantation
JF - Transplantation
IS - 9
ER -